CO-LOCATED EVENTS
NextPrevious

Session

Client Study

Monday, March 17

06:15 PM - 06:45 PM

Live in Everett

Less Details

This session will showcase the remarkable journey of Vertex, which has successfully completed 4 MES upgrades in just 3 years, demonstrating how a strong vendor-customer partnership drives seamless transitions. POMS and Vertex will share real-world insights on how to accelerate MES upgrades while ensuring compliance, minimizing validation efforts, and maximizing business value. Attendees will gain practical strategies for leveraging Product Validation Kits (PVK) to eliminate redundant validation efforts, reducing the burden on internal teams. The session will also highlight how NYMI technology is enhancing MES security and connectivity. You will learn:

  • Proven strategies for fast, efficient MES upgrades with minimal disruption.
  • How Vertex & POMS reduced validation efforts using PVK.
  • Best practices for vendor-customer collaboration to ensure upgrade success.
  • New technologies like NYMI that enhance security and streamline workflows.
  • How to maximize ROI & minimize total cost of ownership with the right MES approach.
Presentation

Speaker

Connor Choate

Sr Solutions Consultant, POMS Corpration

Connor is a highly skilled Senior MES Consultant with over seven years of specialized experience in POMSnet solutions, working with leading global cGMP organizations across biotechnology, engineering, and process manufacturing sectors. His expertise spans all areas of MES, including:

Recipe Authoring & Strategy – Designing and optimizing recipes for seamless execution in POMS Aquila MES.
Installations & Server Architecture – Leading MES deployments with scalable, high-performance system configurations.
Training & Knowledge Transfer – Empowering teams with hands-on MES training, ensuring long-term success.
ERP & Control Layer Integration – Bridging MES with ERP and shop floor systems for end-to-end operational efficiency.
Batch & Discrete Processing – Implementing solutions that enhance both batch and discrete manufacturing processes.
Recognized as a key thought leader and consultant, Connor has played a critical role in configuring the most complex customer processes into efficient, seamless POMS Aquila MES implementations. His deep industry knowledge, problem-solving acumen, and ability to translate business needs into robust technical solutions make him an indispensable asset in the MES space.

With a proven track record of optimizing project outcomes, Connor consistently helps organizations save time, reduce costs, and maximize resource efficiency while ensuring compliance with industry regulations. His strategic mindset, adaptability, and precision-driven approach have earned him a reputation as a trusted advisor and a driving force behind successful MES transformations.

Joseph Ricci

Business Engagement & Technology Senior Principal Analyst, Vertex Pharmaceuticals

Senior IT leader with 35 years of experience in strategic planning, assembling effective teams, and project management. People, the user experience, and enhancing efficiency are at the forefront of a strategic vision. Builds teams that can best achieve clients’ goals, while overseeing projects with the right balance of flexibility and punctuality to ensure that projects save time, resources, and money, year after year.

Managed IT projects in the areas of biotechnology, engineering, and process manufacturing, as well as the US Food and Drug Administration (FDA) approval process. This work has honed skills as a systems developer and architect, and business mentor. From 2010 to 2018, served as Director of Enterprise Information Systems for Fujirebio Diagnostics, Inc. In this role negotiated new licensing agreements and spearheaded data governance and data integration programs that have saved the company over one million dollars in fees and development costs.

Company

POMS Corpration

POMS Corporation is committed to improving the effectiveness, competitiveness and compliance of regulated manufacturers by delivering proven, world-class manufacturing execution system (MES) solutions that integrate seamlessly with other enterprise applications. POMS Corporation’s industry knowledge, validation experience, and MES technology are unparalleled in the cGMP environment. POMS® MES and Business Intelligence Products set the standard for manufacturing in Pharmaceutical, Biotechnology, Medical Device, Consumer Packaged Goods, and other regulated industries.

Vertex Pharmaceuticals

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and have made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continue to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Our global HQ is in Boston, and we have research and development (R&D) sites and commercial offices worldwide. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards.

NextPrevious